How to Cite
Abstract
Worldwide, tobacco use is a major behavioral risk factor for cancer. A comparative study conducted in 2017 showed that 7.10 million deaths were associated with smoking. Tobacco consumption not only increases the risk of developing various forms of cancer, but also reduces life expectancy after suffering a cancer, and increases the risk of relapse. In patients with lung cancer who underwent lung resection, smoking increased the risk of nosocomial mortality by three times and significantly increased the incidence of pulmonary complications. In addition to the localization and stage of cancer, abstinence from tobacco consumption has been noted as the strongest predictor of survival in cancer patients. In the United States, National Recommendations for Comprehensive Cancer Treatment (NCCN) included recommendations for the treatment of nicotine addiction, including 12 weeks of behavioral therapy (including telephone counseling) in combination with smoking cessation drugs for all patients receiving treatment in oncological clinics. Treatment of nicotine addiction has proven cost-effective: in particular, it has been shown for a smoking cessation program prior to surgical resection of the lung. Principles 5 A are recommended by the World Health Organization (WHO) to assist in the smoking cessation. There are national guidelines in other countries. In the Russian Federation, clinical guidelines “Tobacco addiction syndrome, tobacco withdrawal syndrome in adults” were adopted. Given the significant impact of smoking on the prognosis of cancer, the treatment of nicotine addiction should be an integral part of the treatment of malignant tumors. The most effective treatment is the combination of pharmacotherapy and cognitive-behavioral therapy. Teaching behavioral methods to overcome the withdrawal syndrome can be conducted by calling the to Quitline, organized by the Ministry of Health of the Russian Federation.
References
Torre L.A., Siegel R.L., Ward E.M., Jemal A.: Global cancer incidence and mortality rates and trends - an update. Cancer Epidemiol Biomarkers Prev 2016; 25: 16-27 DOI: 10.1158/1055-9965.EPI-15-0578
Torre L.A., Islami F., Siegel R.L. et al. Global Cancer in Women: Burden and Trends.Cancer Epidemiol Biomarkers Prev. 2017;26(4):444-457 DOI: 10.1158/1055-9965.EPI-16-0858
Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой М.: МЧИОИ им. П.А. Герцена, филиал ФГБУ "ЧМИЦ радиологии" Минздрава России, 2018. 250 с. ISBN: 978-5-85502-243-8
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1923-1994 DOI: 10.1016/S0140-6736(18)32225-6
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1659-1724. DOI: 10.1016/S0140-6736(16)31679-8
Walker M.S., Vidrine D.J., Gritz E.R.et al: Smoking relapse during the first year after treatment for early-stage nonsmall-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2370-2377 DOI: 10.1158/1055-9965.EPI-06-0509
Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, et al: Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009; 27: 1969-1975. DOI: 10.1200/JC0.2008.18.2188
Cataldo JK, Dubey S, Prochaska JJ: Smoking cessation: an integral part of lung cancer treatment. Oncology 2010; 78: 289-301. DOI: 10.1159/000319937
Ehlers S.L., Gastineau D.A., Patten C.A. et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant 2011; 46: 285-290 DOI: 10.1038/bmt.2010.113
Bassal R., Schejter E., Bachar R. et al. Risk Factors for Cervical Cancer and CIN3 in Jewish Women in Israel - Two Case Control Studies.Asian Pac. J. Cancer Prev. 2016;17(4): 2067-2073 DOI: 10.7314/apjcp.2016.17.4.2067
Roura E., Castellsagu X., Pawlita M. et al. Smoking as a major risk factor for cervical cancer and precancer:results from the EPIC cohort. Int. J. Cancer 2014; 135 (2): 453-466 DOI: 10.1002/ijc.28666
Заридзе Д.Г Профилактика рака: Руководство для врачей. М.: ИМА-ПРЕСС; 2009.
Левшин В.Ф., Завельская А.Я. Факторы риска и профилактика рака шейки матки. Вопросы онкологии 2017; 63(3): 506-516.
Титова О.Н., Суховская О.А., Пирумов П.А. и др. Анализ различных видов помощи при отказе от табакокурения. Вестник Санкт-Петербургского университета, Медицина 2011; (1): 49-55.
Moyer V.A. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160: 330-338 DOI: 10.7326/M13-2771
Jensen K., Jensen A.B., Grau C. Smoking has a negative impact upon health related quality of life after treatment for head and neck cancer. Oral Oncol 2007; 43: 187-192 DOI: 10.1016/j.oraloncology.2006.02.006
Romaszko-Wojtowicz A., Bucinski A., Doboszynska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clin Exp Med. 2018;18(3):391-397 DOI: 10.1007/s10238-018-0498-1
Lassen P., Lacas B., Pignon J.P et al. MARCH Collaborative Group. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. Radiother Oncol. 2018;126(1):107-115 DOI: 10.1016/j.radonc.2017.10.018
Mason D.P., Subramanian S., Nowicki E.R. et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg 2009; 88: 362-371. DOI: 10.1053/ejso.2002.1308
Lugg S.T., Tikka T., Agostini P.J. et al. Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery.J Cardiothorac Surg. 2017;12(1):52 DOI: 10.1186/s13019-017-0614-4
S0rensen L.T., H0rby J., Friis E. et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002; 28: 815-820 DOI: 10.1053/ejso.2002.1308
Ehlers S.L., Gastineau D.A., Patten C.A. et al: The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant 2011; 46: 285-290. DOI: 10.1038/bmt.2010.113
Karam-Hage M., Cinciripini P.M., Gritz E.R. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014;64(4):272-90 DOI: 10.3322/caac.21231
Campling B.G., Ye Z., Lai Y et al. Disparity in age at lung cancer diagnosis between current and former smokers. J Cancer Res Clin Oncol. 2019;145(5):1243-1251 DOI: 10.1007/s00432-019-02875-6.000
Rabius V., Karam-Hage M., Blalock J.A., Cinciripini P.M. "Meaningful use" provides a meaningful opportunity. Cancer 2014; 120: 464-468. DOI: 10.1002/cncr.28436
Walker M.S., Vidrine D.J., Gritz E.R. et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2370-2377 DOI: 10.1158/1055-9965.EPI-06-0509
Martinez Ü., Brandon T.H., Sutton S.K., Simmons V.N. Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 2018;27(9):2104-2110 DOI: 10.1002/pon.4774
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Smoking Cessa tion Version 1.2017. 2017. DOI: 10.7326/AITC201603010
Slatore C.G., Au D.H., Hollingworth W.Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer. J Thorac Oncol 2009; 4: 499-504 DOI: 10.1097/JTO.0b013e318195e23a
Warren G.W., Marshall J.R., Cummings K.M. et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract 2013; 9: 258-262 DOI: 10.1200/JOP.2013.001025
Fiore M.C., Jaen C.R., Baker T.B. et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service report. Am J Prev Med 2008; 35: 158-176 DOI: 10.1016/j.amepre.2008.04.009
National Institute for Health Care Excellence: Smoking: reducing and preventing tobacco use. 2015. https://www. nice.org.uk/guidance/qs82 (accessed June 4, 2019).
Чучалин А.Г., Сахарова ГМ., Антонов Н.С. и др. Синдром зависимости от табака, синдром отмены табака у взрослых. клинические рекомендации. Наркология 2018; 17(3): 3 - 21.
Cahill K., Stevens S., Perera R,.Lancaster T.: Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013; 5:CD009329 DOI: 10.1002/14651858.CD009329.pub2
Price S., Hitsman B., Veluz-Wilkins A. et al. The use of varenicline to treat nicotine dependence among patients with cancer. Psychooncology 2017; 26: 1526-1534. DOI: 10.1002/pon.4166
Carroll A.J., Kim K., Miele A. et al. Longitudinal associations between smoking and affect among cancer ВОПРОСЫ ОНКОЛОГИИ. 2020, ТОМ 66, № 1 patients using varenicline to quit smoking.Addict Behav. 2019;95:206-210. DOI: 10.1016/j.addbeh.2019.04.003
Lancaster T., stead L.F. Individual behavioural counselling for smoking cessation. Cochrane Database syst Rev 2017;CD001292. DOI: 10.1002/14651858.CD001292.pub3
Stead L.F., Hartmann-Boyce J., Perera R., Lancaster I: telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013; 8:CD002850. DOI: 10.1002/14651858.CD002850.pub3
Matkin W., Ordonez-Mena J.M., Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019 May 2;5:CD002850. DOI: 10.1002/14651858.CD002850.pub4
Яблонский П.К., Суховская O.A. Организация консультативной телефонной помощи при отказе от табакокурения в Российской федерации. Здравоохранение Российской Федерации 2014; 58(1): 30-33.
Mehnert A., Brähler E., Faller H et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014; 32: 3540-3546 DOI: 10.1200/JC0.2014.56.0086
Duffy S.A., Ronis D.L., Valenstein M.et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2006; 15: 2203-2208. DOI: 10.1158/1055-9965.EPI-05-0880
Nayan S., Gupta M.K., Strychowsky J.E., Sommer D.D. smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg 2013; 149: 200-211 DOI: 10.1177/0194599813490886
Klemp I., Steffenssen M., Bakholdt V. Counseling is effective for smoking cessation in head and neck cancer patients - a systematic review and meta-analysis. J Oral Maxillofac Surg 2016; 74: 1687-1694 DOI: 10.1016/j.joms.2016.02.003
Kaiser E.G., Prochaska J.J., Kendra M.S. Tobacco Cessation in Oncology Care. Oncology 2018;95:129-137 DOI: 10.1159/000489266
Суховская O.A., Смирнова M.A. Сочетанное применение никотинсодержащей жевательной резинки и когнитивно-поведенческой терапии при отказе от табакокурения. Профилактическая медицина 2015; 18(5): 70-74.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2020